Mouse Anti-CBR1 Recombinant Antibody (4G11-1C7) (CBMAB-C6975-LY)

Mao, L., Wang, K., Zhang, P., Ren, S., Sun, J., Yang, M., ... & Sun, B. (2021). Carbonyl Reductase 1 Attenuates Ischemic Brain Injury by Reducing Oxidative Stress and Neuroinflammation. Translational Stroke Research, 1-14.

Bell, R. M., Villalobos, E., Nixon, M., Miguelez-Crespo, A., Murphy, L., Fawkes, A., ... & Morgan, R. A. (2021). Carbonyl reductase 1 amplifies glucocorticoid action in adipose tissue and impairs glucose tolerance in lean mice. Molecular metabolism, 48, 101225.

Yun, M., Choi, A. J., Woo, S. R., Noh, J. K., Sung, J. Y., Lee, J. W., & Eun, Y. G. (2020). Inhibition of Carbonyl Reductase 1 Enhances Metastasis of Head and Neck Squamous Cell Carcinoma through β-catenin-Mediated Epithelial-Mesenchymal Transition. Journal of Cancer, 11(3), 533.

Koczurkiewicz-Adamczyk, P., Piska, K., Gunia-Krzyżak, A., Bucki, A., Jamrozik, M., Lorenc, E., ... & Pękala, E. (2020). Cinnamic acid derivatives as chemosensitising agents against DOX-treated lung cancer cells–Involvement of carbonyl reductase 1. European Journal of Pharmaceutical Sciences, 154, 105511.

Kajimura, T., Sato, S., Murakami, A., Hayashi‑Okada, M., Nakashima, K., Sueoka, K., & Sugino, N. (2019). Overexpression of carbonyl reductase 1 inhibits malignant behaviors and epithelial mesenchymal transition by suppressing TGF‑β signaling in uterine leiomyosarcoma cells. Oncology letters, 18(2), 1503-1512.

Seliger, J. M., Martin, H. J., Maser, E., & Hintzpeter, J. (2019). Potent inhibition of human carbonyl reductase 1 (CBR1) by the prenylated chalconoid xanthohumol and its related prenylflavonoids isoxanthohumol and 8-prenylnaringenin. Chemico-biological interactions, 305, 156-162.

Piska, K., Koczurkiewicz, P., Wnuk, D., Karnas, E., Bucki, A., Wójcik-Pszczoła, K., ... & Pękala, E. (2019). Synergistic anticancer activity of doxorubicin and piperlongumine on DU-145 prostate cancer cells–the involvement of carbonyl reductase 1 inhibition. Chemico-biological interactions, 300, 40-48.

Yun, M., Choi, A. J., Lee, Y. C., Kong, M., Sung, J. Y., Kim, S. S., & Eun, Y. G. (2018). Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma. Journal of Experimental & Clinical Cancer Research, 37(1), 1-12.

Yamanouchi, R., Harada, K., Ferdous, T., & Ueyama, Y. (2018). Low carbonyl reductase 1 expression is associated with poor prognosis in patients with oral squamous cell carcinoma. Molecular and clinical oncology, 8(3), 400-406.

Shi, S. M., & Di, L. (2017). The role of carbonyl reductase 1 in drug discovery and development. Expert opinion on drug metabolism & toxicology, 13(8), 859-870.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols